Point72 Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $88.1M | Buy |
95,766
+28,020
| +41% | +$28.4M | 0.11% | 198 |
|
|
2025
Q4 | $72.8M | Buy |
67,746
+60,627
| +852% | +$58M | 0.08% | 277 |
|
|
2025
Q3 | $5.43M | Sell |
7,119
-181,391
| -96% | -$135M | 0.01% | 1033 |
|
|
2025
Q2 | $147M | Buy |
188,510
+133,736
| +244% | +$104M | 0.29% | 68 |
|
|
2025
Q1 | $45.2M | Buy |
+54,774
| New | +$45.6M | 0.1% | 235 |
|
|
2024
Q4 | – | Sell |
-13,158
| Closed | -$10.9M | – | 2280 |
|
|
2024
Q3 | $11.7M | Buy |
+13,158
| New | +$11.8M | 0.03% | 595 |
|
|
2024
Q2 | – | Sell |
-125,910
| Closed | -$98M | – | 2186 |
|
|
2024
Q1 | $98M | Sell |
125,910
-45,301
| -26% | -$32.2M | 0.24% | 88 |
|
|
2023
Q4 | $99.8M | Sell |
171,211
-11,417
| -6% | -$6.66M | 0.24% | 92 |
|
|
2023
Q3 | $98.1M | Buy |
182,628
+90,706
| +99% | +$46.7M | 0.29% | 69 |
|
|
2023
Q2 | $43.1M | Buy |
91,922
+87,497
| +1,977% | +$36.7M | 0.13% | 201 |
|
|
2023
Q1 | $1.52M | Buy |
+4,425
| New | +$1.49M | ﹤0.01% | 1034 |
|
|
2022
Q4 | – | Sell |
-289,155
| Closed | -$93.5M | – | 1673 |
|
|
2022
Q3 | $93.5M | Sell |
289,155
-6,645
| -2% | -$2.11M | 0.37% | 51 |
|
|
2022
Q2 | $95.9M | Buy |
+295,800
| New | +$88.8M | 0.4% | 48 |
|
|
2022
Q1 | – | Sell |
-280,300
| Closed | -$77.4M | – | 1291 |
|
|
2021
Q4 | $77.4M | Buy |
280,300
+193,200
| +222% | +$49M | 0.31% | 66 |
|
|
2021
Q3 | $20.1M | Buy |
+87,100
| New | +$21.5M | 0.09% | 305 |
|
|
2021
Q1 | – | Sell |
-837,100
| Closed | -$141M | – | 1079 |
|
|
2020
Q4 | $141M | Sell |
837,100
-479,441
| -36% | -$71.6M | 0.69% | 20 |
|
|
2020
Q3 | $195M | Buy |
+1,316,541
| New | +$204M | 1% | 10 |
|
|
2020
Q1 | – | Sell |
-580,933
| Closed | -$76.4M | – | 947 |
|
|
2019
Q4 | $76.4M | Sell |
580,933
-325,828
| -36% | -$37.8M | 0.4% | 62 |
|
|
2019
Q3 | $101M | Buy |
+906,761
| New | +$101M | 0.62% | 31 |
|
|
2019
Q1 | – | Sell |
-318,673
| Closed | -$36.9M | – | 1131 |
|
|
2018
Q4 | $36.9M | Buy |
318,673
+268,673
| +537% | +$30M | 0.18% | 150 |
|
|
2018
Q3 | $5.37M | Sell |
50,000
-695,800
| -93% | -$69.6M | 0.02% | 580 |
|
|
2018
Q2 | $63.6M | Sell |
745,800
-152,891
| -17% | -$12.6M | 0.25% | 109 |
|
|
2018
Q1 | $69.5M | Buy |
898,691
+251,891
| +39% | +$20.3M | 0.29% | 91 |
|
|
2017
Q4 | $54.6M | Buy |
646,800
+46,800
| +8% | +$3.98M | 0.24% | 119 |
|
|
2017
Q3 | $51.3M | Sell |
600,000
-678,149
| -53% | -$55.6M | 0.23% | 112 |
|
|
2017
Q2 | $105M | Buy |
1,278,149
+375,549
| +42% | +$30.6M | 0.59% | 24 |
|
|
2017
Q1 | $75.9M | Buy |
902,600
+895,700
| +12,981% | +$71.7M | 0.42% | 49 |
|
|
2016
Q4 | $507K | Sell |
6,900
-301,500
| -98% | -$22.5M | ﹤0.01% | 631 |
|
|
2016
Q3 | $24.8M | Sell |
308,400
-1,041,880
| -77% | -$83.4M | 0.17% | 152 |
|
|
2016
Q2 | $106M | Buy |
1,350,280
+120,676
| +10% | +$9.09M | 0.72% | 16 |
|
|
2016
Q1 | $88.5M | Buy |
1,229,604
+455,404
| +59% | +$34.5M | 0.68% | 20 |
|
|
2015
Q4 | $65.2M | Sell |
774,200
-695,100
| -47% | -$57.7M | 0.54% | 43 |
|
|
2015
Q3 | $123M | Buy |
+1,469,300
| New | +$124M | 0.97% | 10 |
|
|
2015
Q1 | – | Sell |
-76,000
| Closed | -$5.24M | – | 745 |
|
|
2014
Q4 | $5.24M | Buy |
+76,000
| New | +$5.13M | 0.04% | 424 |
|
Other funds holding LLY
VCM
VPM
Point72 Asset Management's LLY Position: Q1 2026 in Review
Point72 Asset Management increased its Eli Lilly (LLY) stake by 41% in Q1 2026, buying an estimated $28.4M and bringing the position to 95,766 shares worth $88.1M. The position accounts for 0.11% of the portfolio, ranked #198.
Point72 Asset Management first reported a position in LLY in Q4 2014 and has held it in 34 quarters since. The position peaked at $195M in Q3 2020. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Point72 Asset Management held 95,766 shares of Eli Lilly worth $88.1M as of Q1 2026.
- Point72 Asset Management bought 28,020 Eli Lilly shares in Q1 2026, an estimated $28.4M.
- Eli Lilly made up 0.11% of Point72 Asset Management's portfolio in Q1 2026, its #198 holding.
- Point72 Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 34 quarters since.
- Point72 Asset Management's Eli Lilly position peaked at $195M in Q3 2020.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.